A new Micromonospora-produced macrolide antibiotic, rosamicin.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D001419:Bacteria / Q000187:drug effects; D002855:Chromatography, Thin Layer; D004352:Drug Resistance, Microbial; D004355:Drug Stability; D004917:Erythromycin / Q000494:pharmacology; D006358:Hot Temperature; D006863:Hydrogen-Ion Concentration; D007928:Lethal Dose 50; D051379:Mice; D008826:Microbial Sensitivity Tests; D008847:Micromonospora / Q000032:analysis*; D009174:Mycoplasma / Q000187:drug effects; D012995:Solubility; D013203:Staphylococcal Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D004917:Erythromycin